TCM Biotech International Corp. (TPEX:4169)

TCM Biotech International Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 21, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	10,835	3,419	3,437	1,502	1,819	1,713
Market Cap Growth	215.29%	-0.52%	128.87%	-17.43%	6.17%	62.78%
Enterprise Value	10,358	2,966	3,518	1,592	1,930	1,741
Last Close Price	183.50	57.70	57.70	29.09	35.68	33.23
PE Ratio	514.06	162.73	185.02	82.21	970.95	67.06
PS Ratio	15.88	5.13	3.54	1.87	2.59	2.32
PB Ratio	10.21	3.23	3.26	2.80	3.51	3.31
P/TBV Ratio	10.24	3.24	3.28	2.85	3.60	3.41
P/FCF Ratio	297.89	21.45	-	30.98	162.55	23.80
P/OCF Ratio	268.49	20.42	-	28.74	118.66	22.87
EV/Sales Ratio	15.18	4.45	3.63	1.98	2.75	2.36
EV/EBITDA Ratio	232.43	103.67	89.02	38.95	117.57	34.58
EV/EBIT Ratio	-	277.32	157.56	62.91	905.86	46.99
EV/FCF Ratio	284.77	18.61	-	32.84	172.54	24.19
Debt / Equity Ratio	0.04	0.04	0.11	0.29	0.31	0.25
Debt / EBITDA Ratio	0.88	1.33	2.71	3.60	8.66	2.49
Debt / FCF Ratio	1.07	0.27	-	3.25	14.39	1.79
Asset Turnover	-	0.53	0.89	0.95	0.88	0.96
Inventory Turnover	-	1.99	2.44	1.79	1.67	1.82
Quick Ratio	8.20	8.24	3.87	1.42	1.42	1.74
Current Ratio	10.03	9.91	4.95	2.29	2.67	3.69
Return on Equity (ROE)	-	1.99%	2.33%	3.46%	0.36%	4.97%
Return on Assets (ROA)	-	0.53%	1.28%	1.88%	0.17%	3.01%
Return on Invested Capital (ROIC)	3.45%	1.45%	2.96%	3.26%	0.29%	4.21%
Return on Capital Employed (ROCE)	2.00%	1.00%	2.00%	4.00%	0.30%	5.60%
Earnings Yield	0.19%	0.61%	0.54%	1.22%	0.10%	1.49%
FCF Yield	0.34%	4.66%	-1.21%	3.23%	0.61%	4.20%
Dividend Yield	0.19%	0.61%	0.49%	0.11%	-	1.05%
Payout Ratio	98.05%	80.10%	8.71%	-	903.20%	73.59%
Buyback Yield / Dilution	-0.87%	-11.37%	-8.03%	-0.89%	-0.42%	0.03%
Total Shareholder Return	-0.68%	-10.76%	-7.54%	-0.77%	-0.42%	1.08%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.